• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病免疫学的最新进展。

Current Developments in the Immunology of Psoriasis.

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Department of Molecular Pathology, Institute of Pathology, University of Würzburg, Würzburg, Germany.

出版信息

Yale J Biol Med. 2020 Mar 27;93(1):97-110. eCollection 2020 Mar.

PMID:32226340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7087066/
Abstract

Psoriasis is a frequent inflammatory skin disease. Fundamental research on the pathogenesis of psoriasis has substantially increased our understanding of skin immunology, which has helped to introduce innovative and highly effective therapies. Psoriasis is a largely T lymphocyte-mediated disease in which activation of innate immune cells and pathogenic T cells result in skin inflammation and hyperproliferation of keratinocytes. B cells have thus far largely been neglected regarding their role for the pathogenesis of psoriasis. However, recent data shed light on their role in inflammatory skin diseases. Interestingly, interleukin (IL)-10-producing regulatory B cells have been assumed to ameliorate psoriasis. In this review, we will discuss the development of disease, pathogenicity, and current developments in therapeutic options. We describe different roles of T cells, B cells, and cytokines for the immunopathology and disease course of psoriasis.

摘要

银屑病是一种常见的炎症性皮肤病。对银屑病发病机制的基础研究极大地提高了我们对皮肤免疫学的认识,这有助于引入创新和高效的治疗方法。银屑病在很大程度上是一种 T 淋巴细胞介导的疾病,其中先天免疫细胞和致病 T 细胞的激活导致皮肤炎症和角质形成细胞的过度增殖。迄今为止,B 细胞在银屑病发病机制中的作用在很大程度上被忽视了。然而,最近的数据揭示了它们在炎症性皮肤病中的作用。有趣的是,产生白细胞介素 (IL)-10 的调节性 B 细胞被认为可以改善银屑病。在这篇综述中,我们将讨论疾病的发展、发病机制和治疗选择的最新进展。我们描述了 T 细胞、B 细胞和细胞因子在银屑病的免疫病理学和疾病过程中的不同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7087066/380547ed3e97/yjbm_93_1_97_g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7087066/380547ed3e97/yjbm_93_1_97_g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7087066/380547ed3e97/yjbm_93_1_97_g01.jpg

相似文献

1
Current Developments in the Immunology of Psoriasis.银屑病免疫学的最新进展。
Yale J Biol Med. 2020 Mar 27;93(1):97-110. eCollection 2020 Mar.
2
Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.布鲁顿酪氨酸激酶抑制剂通过调节固有免疫细胞中的 IL-23/IL-17A 抑制咪喹莫特诱导的小鼠银屑病样炎症。
Int Immunopharmacol. 2020 Mar;80:106215. doi: 10.1016/j.intimp.2020.106215. Epub 2020 Jan 24.
3
Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.靶向固有和适应性 T 细胞中的 L 型氨基酸转运蛋白 1 可有效控制皮肤炎症。
J Allergy Clin Immunol. 2020 Jan;145(1):199-214.e11. doi: 10.1016/j.jaci.2019.09.025. Epub 2019 Oct 9.
4
Innate Lymphocytes in Psoriasis.银屑病中的固有淋巴细胞。
Front Immunol. 2020 Feb 21;11:242. doi: 10.3389/fimmu.2020.00242. eCollection 2020.
5
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.IL-37 通过抑制促炎细胞因子的产生来改善银屑病的炎症过程。
J Immunol. 2014 Feb 15;192(4):1815-23. doi: 10.4049/jimmunol.1300047. Epub 2014 Jan 22.
6
Innate immunity in the pathogenesis of psoriasis.固有免疫在银屑病发病机制中的作用。
Arch Dermatol Res. 2011 Dec;303(10):691-705. doi: 10.1007/s00403-011-1169-1. Epub 2011 Aug 24.
7
The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.Toll 样受体在皮肤宿主防御、银屑病和特应性皮炎中的作用。
J Immunol Res. 2019 Nov 14;2019:1824624. doi: 10.1155/2019/1824624. eCollection 2019.
8
Skin immunity and its dysregulation in psoriasis.皮肤免疫及其在银屑病中的失调。
Cell Cycle. 2019 Oct;18(20):2581-2589. doi: 10.1080/15384101.2019.1653099. Epub 2019 Aug 15.
9
Innate lymphoid cells in the skin.皮肤中的固有淋巴细胞。
J Invest Dermatol. 2015 Mar;135(3):673-678. doi: 10.1038/jid.2014.401. Epub 2014 Oct 23.
10
Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis.皮肤微生物失调与银屑病宿主免疫系统的相互作用:潜在发病机制。
Front Immunol. 2021 Oct 18;12:764384. doi: 10.3389/fimmu.2021.764384. eCollection 2021.

引用本文的文献

1
Gene hydrogel platforms for targeted skin therapy: bridging hereditary disorders, chronic wounds, and immune related skin diseases.用于靶向皮肤治疗的基因水凝胶平台:连接遗传性疾病、慢性伤口和免疫相关皮肤病。
Front Drug Deliv. 2025 Jul 1;5:1598145. doi: 10.3389/fddev.2025.1598145. eCollection 2025.
2
Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors.接受白细胞介素-17抑制剂治疗的银屑病患者的不良事件和免疫反应
Acta Derm Venereol. 2025 Aug 18;105:adv43685. doi: 10.2340/actadv.v105.43685.
3
Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like dermatitis by modulating ERK and NF-κB signaling pathways in mice.

本文引用的文献

1
Neutrophils in Psoriasis.银屑病中的中性粒细胞。
Front Immunol. 2019 Oct 9;10:2376. doi: 10.3389/fimmu.2019.02376. eCollection 2019.
2
T Cells Control Chemokine Secretion by Keratinocytes.T 细胞通过角质形成细胞控制趋化因子的分泌。
Front Immunol. 2019 Aug 9;10:1917. doi: 10.3389/fimmu.2019.01917. eCollection 2019.
3
The importance of the neuro-immuno-cutaneous system on human skin equivalent design.神经免疫皮肤系统对人类皮肤等效物设计的重要性。
羟基酪醇通过调节小鼠的ERK和NF-κB信号通路改善咪喹莫特诱导的银屑病样皮炎。
Sci Rep. 2025 Aug 17;15(1):30125. doi: 10.1038/s41598-025-16198-9.
4
Immunomodulatory actions of tonifying polysaccharides: pharmacological effects, mechanisms and therapeutic applications.补益多糖的免疫调节作用:药理作用、机制及治疗应用
Front Immunol. 2025 Jul 22;16:1640679. doi: 10.3389/fimmu.2025.1640679. eCollection 2025.
5
Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).子宫内膜异位症与银屑病及银屑病关节炎的共病现象:遗传学见解(综述)
Exp Ther Med. 2025 Jul 10;30(3):171. doi: 10.3892/etm.2025.12921. eCollection 2025 Sep.
6
Identification of PRKCQ-AS1 as a Keratinocyte-Derived Exosomal lncRNA That Promotes Th17 Differentiation and IL-17 secretion in Psoriasis Through Bioinformatics, Machine Learning Algorithms, and Cell Experiments.通过生物信息学、机器学习算法和细胞实验鉴定PRKCQ-AS1为一种角质形成细胞来源的外泌体长链非编码RNA,其在银屑病中促进Th17分化和IL-17分泌
J Inflamm Res. 2025 May 22;18:6557-6582. doi: 10.2147/JIR.S521553. eCollection 2025.
7
Multimodal Function of Mesenchymal Stem Cells in Psoriasis Treatment.间充质干细胞在银屑病治疗中的多模态功能
Biomolecules. 2025 May 19;15(5):737. doi: 10.3390/biom15050737.
8
Unique advantages and applications of polysaccharide microneedles as drug delivery materials and in treatment of skin diseases.多糖微针作为药物递送材料在皮肤病治疗中的独特优势及应用
Nanoscale Adv. 2025 Apr 12. doi: 10.1039/d4na01083c.
9
Immune-related hub genes and their role in psoriasis pathogenesis.免疫相关枢纽基因及其在银屑病发病机制中的作用。
Sci Rep. 2025 May 22;15(1):17765. doi: 10.1038/s41598-025-02822-1.
10
Immunomodulatory interactions between mesenchymal stromal/stem cells and immune cells in psoriasis: therapeutic potential and challenges.银屑病中间充质基质/干细胞与免疫细胞之间的免疫调节相互作用:治疗潜力与挑战
Stem Cell Res Ther. 2025 May 14;16(1):241. doi: 10.1186/s13287-025-04375-6.
Cell Prolif. 2019 Nov;52(6):e12677. doi: 10.1111/cpr.12677. Epub 2019 Aug 23.
4
Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders.银屑病及其他炎症性疾病中的适应性免疫和固有免疫。
Front Immunol. 2019 Jul 26;10:1764. doi: 10.3389/fimmu.2019.01764. eCollection 2019.
5
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.利斯库珠单抗与阿达木单抗治疗中重度斑块型银屑病患者的疗效比较(IMMvent):一项随机、双盲、活性对照的 3 期临床试验。
Lancet. 2019 Aug 17;394(10198):576-586. doi: 10.1016/S0140-6736(19)30952-3. Epub 2019 Jul 4.
6
Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis.中重度银屑病患者合并焦虑和抑郁的患病率及经济负担。
J Med Econ. 2019 Dec;22(12):1290-1297. doi: 10.1080/13696998.2019.1638788. Epub 2019 Jul 12.
7
Biosimilars for the treatment of psoriasis.用于治疗银屑病的生物类似药。
Expert Opin Biol Ther. 2019 Oct;19(10):993-1000. doi: 10.1080/14712598.2019.1636963. Epub 2019 Jul 1.
8
Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.治疗银屑病的选择性 IL-23p19 抑制剂的安全性。
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1676-1684. doi: 10.1111/jdv.15653. Epub 2019 Jun 27.
9
Psoriasis Pathogenesis and Treatment.银屑病发病机制与治疗。
Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475.
10
Skin-Associated B Cells in Health and Inflammation.皮肤相关 B 细胞在健康与炎症中的作用
J Immunol. 2019 Mar 15;202(6):1659-1666. doi: 10.4049/jimmunol.1801211.